In studies related to non-alcoholic steatohepatitis (NASH), a significant decrease in circulating CDCP1 was observed after weight loss surgery, and CDCP1 levels showed a close correlation with liver injury markers ALT and AST, suggesting CDCP1 may be a risk factor for NASH (37). Here, CDCP1 is linked to metabolic dysfunction-associated steatohepatitis.